Clincosm LogoSign in Get a demo

Bladder Cancer

Showing NaN - NaN of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cisplatin-Ineligible Metastatic Bladder Cancer and The Role of

Not yet recruiting
  • Bladder Cancer
  • +3 more
  • Geriatric-8 Survey
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Urologic Cancer, Urologic Tumors, Bladder Cancer Trial in Boston (Electromagnetic Guided Laparoscopy, Ultrasound)

Not yet recruiting
  • Urologic Cancer
  • +7 more
  • Electromagnetic Guided Laparoscopy
  • Ultrasound
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 8, 2023

Bladder Cancer, Cystectomy Trial in Boston (Exercise Training, Nutritional Intervention)

Not yet recruiting
  • Bladder Cancer
  • Cystectomy
  • Exercise Training
  • Nutritional Intervention
  • Boston, Massachusetts
  • +1 more
Jan 27, 2023

Urothelial Carcinoma, Bladder Cancer Trial in United States (drug, radiation, biological)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Durvalumab (Cohort 1-3)
  • +7 more
  • Phoenix, Arizona
  • +10 more
Jan 11, 2023

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Intravesical Therapy and Surgery as Treatment Options for

Recruiting
  • Bladder Cancer
  • +2 more
    • Birmingham, Alabama
    • +37 more
    Nov 28, 2022

    Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in

    Recruiting
    • Urothelial Cancer
    • +3 more
    • Sacituzumab Govitecan (SG)
    • Enfortumab vedotin-ejfv (EV)
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Sep 28, 2022

    Biomarkers in Subjects With Untreated Solid Tumors

    Completed
    • Breast Cancer
    • +12 more
    • Blood Sample Collection
    • Phoenix, Arizona
    • +118 more
    Aug 31, 2022

    Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

    Active, not recruiting
    Has Results
    • Metastatic Cancer
    • +9 more
    • Mobile, Alabama
    • +19 more
    Aug 1, 2022

    NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +12 more
    • Tucson, Arizona
    • +26 more
    Aug 1, 2022

    Bladder Cancer Trial in Canada, United States (therapeutic conventional surgery, therapeutic standard lymphadenectomy,

    Active, not recruiting
    • Bladder Cancer
    • therapeutic conventional surgery
    • +2 more
    • Los Angeles, California
    • +34 more
    Jul 20, 2022

    Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102)

    Recruiting
    • Bladder Cancer
    • +2 more
    • Tucson, Arizona
    • +76 more
    Jul 13, 2022

    Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)

    Completed
    Has Results
    • Bladder Cancer
    • Urothelial Carcinoma
    • Birmingham, Alabama
    • +34 more
    Jul 7, 2022

    Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

    Recruiting
    • Ovarian Cancer
    • +10 more
    • West Hollywood, California
    • +27 more
    Jun 27, 2022

    Bladder Cancer, Urothelial Carcinoma Trial in Boston (18F-fluciclovine, PET/CT)

    Recruiting
    • Bladder Cancer
    • Urothelial Carcinoma
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Apr 4, 2022

    Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

    Completed
    • Prostate Cancer
    • +6 more
    • MGA271
    • Los Angeles, California
    • +11 more
    Feb 4, 2022

    Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

    Terminated
    • Mesothelioma
    • +12 more
    • MGD009
    • Los Angeles, California
    • +19 more
    Feb 4, 2022

    Bladder Cancer, Urinary Bladder Tumor, Urologic Tumors Trial in Los Angeles, Boston (Fiducial marker placement, Multiparametric

    Recruiting
    • Bladder Cancer
    • +4 more
    • Fiducial marker placement
    • Multiparametric MRI (mpMRI)
    • Los Angeles, California
    • +1 more
    Jan 7, 2022

    Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Boston (Pembrolizumab, Cryoablation)

    Recruiting
    • Metastatic Urothelial Carcinoma
    • Bladder Cancer
    • Boston, Massachusetts
    • +1 more
    Oct 27, 2021

    Bladder Cancer Trial in Canada, United States (Vicinium)

    Active, not recruiting
    • Bladder Cancer
    • Vicinium
    • Birmingham, Alabama
    • +69 more
    Jun 10, 2021

    Bladder Cancer Trial in Canada, United States (drug, procedure, radiation)

    Completed
    • Bladder Cancer
    • Birmingham, Alabama
    • +228 more
    Oct 19, 2020

    Longer-term Recurrence Rates in Bladder Cancer After

    Completed
    Has Results
    • Bladder Cancer
      • Stanford, California
      • +23 more
      Mar 28, 2019

      Transitional Cell Carcinoma, Bladder Cancer Trial in Boston (Docetaxel, vandetanib, Placebo)

      Completed
      Has Results
      • Transitional Cell Carcinoma
      • Bladder Cancer
      • Boston, Massachusetts
      • +2 more
      Aug 20, 2018